Akari Therapeutics Plc (AKTX)
0.24
-0.01
(-2.68%)
USD |
NASDAQ |
Mar 06, 09:35
Akari Therapeutics Cash from Investing (TTM) : 0.382M for Sept. 30, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| DBV Technologies SA | 0.1363M |
| Cellectis SA | -68.81M |
| Biodexa Pharmaceuticals Plc | -0.4065M |
| NuCana Plc | -0.2609M |
| Autolus Therapeutics Plc | -311.41M |